Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ian D. Kamaly-Asl"'
Autor:
A. Saam Youshani, Samuel Rowlston, Claire O’Leary, Gabriella Forte, Helen Parker, Aiyin Liao, Brian Telfer, Kaye Williams, Ian D. Kamaly-Asl, Brian W. Bigger
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Abstract Background Chimeric mouse models generated via adoptive bone marrow transfer are the foundation for immune cell tracking in neuroinflammation. Chimeras that exhibit low chimerism levels, blood-brain barrier disruption and pro-inflammatory ef
Externí odkaz:
https://doaj.org/article/24b3db9776604feebdfec27f8592cf84
Autor:
Lucie, Lafay-Cousin, Donald J, Mabbott, William, Halliday, Michael D, Taylor, Uri, Tabori, Ian D, Kamaly-Asl, Abhaya V, Kulkarni, Ute, Bartels, Mark, Greenberg, Eric, Bouffet
Publikováno v:
Journal of neurosurgery. Pediatrics. 5(6)
Choroid plexus carcinomas (CPCs) are rare pediatric tumors with a generally poor prognosis. Although the role of surgery is well recognized, the role of adjuvant chemotherapy and radiation therapy remains unclear. In this paper, the authors' goal was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b17d8d0b8b849bbfe142aefb9df2a7e6
https://pubmed.ncbi.nlm.nih.gov/20515336
https://pubmed.ncbi.nlm.nih.gov/20515336
Autor:
Ian D. Kamaly-Asl, James M. Drake
Publikováno v:
Neuro-Oncology of CNS Tumors ISBN: 3540258337
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b170ec1f5919181a81b222b62b459a80
https://doi.org/10.1007/3-540-31260-9_29
https://doi.org/10.1007/3-540-31260-9_29
Autor:
Kenny Kwok-Hei Yu, Jessica T Taylor, Omar N Pathmanaban, Amir Saam Youshani, Deniz Beyit, Joanna Dutko-Gwozdz, Roderick Benson, Gareth Griffiths, Ian Peers, Peter Cueppens, Brian A Telfer, Kaye J Williams, Catherine McBain, Ian D Kamaly-Asl, Brian W Bigger
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193694 (2018)
Glioblastoma (GBM) is the most common primary brain malignancy in adults, yet survival outcomes remain poor. First line treatment is well established, however disease invariably recurs and improving prognosis is challenging. With the aim of personali
Externí odkaz:
https://doaj.org/article/c0919e2e2f8a4abbb588898382f3d76c